Pubblicazioni Scientifiche
Dermatologia25 set 2026
Effect of semaglutide on hidradenitis suppurativa disease
Effect of semaglutide
25 set 2026
Systemic Inflammatory Indexes as Easy-to-Use Markers for Monitoring Psoriasis
Systemic Inflammatory Indexes as Easy-to-Use Markers
25 set 2026
Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals
In patients with moderate atopic dermatitis (AD), topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) often do not sufficiently control AD signs/symptoms
25 set 2026
Clinical Trial Eligibility in Atopic Dermatitis
Randomized clinical trials (RCTs) in atopic dermatitis (AD) often exclude older adults and patients with comorbidities, limiting the generalizability of trial findings to real-world populations
14 set 2026
Topical Preparations for Moderate to Severe Rosacea Treatment
Comparative efficacy and tolerability of topical therapies for rosacea
14 set 2026
Amitriptyline oral drops for the treatment of burning mouth syndrome
Burning mouth syndrome (BMS) is a chronic oral neuropathic pain disorder
14 set 2026
Tattoo-Induced Cutaneous Lymphoid Hyperplasia
The increasing popularity of tattoos has been paralleled by a rise in tattoo-related skin reactions
27 ago 2026
Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy
The expanding use of biologic and oral targeted therapies has transformed the management of psoriasis and atopic dermatitis.
27 ago 2026
Effectiveness of scabies treatments in Italy
Scabies is a neglected tropical disease with a worldwide distribution.
27 ago 2026
Clinical and dermoscopic triage of head and neck macules
Flat head/neck pigmented macules can be diagnostically challenging.
24 lug 2026
Systemic Immune-Inflammation Index (SII)
The Systemic Immune-Inflammation Index (SII), derived from routine blood counts, has emerged as a potential marker
24 lug 2026
Denifanstat for moderate-to-severe acne
Acne vulgaris is a common chronic inflammatory skin
24 lug 2026
Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor
Biologics have emerged in recent years as relatively safe
15 lug 2026
A 14-year multicentric follow-up study of atypical pemphigus
The clinical, epidemiological and immunopathological profiles of atypical forms of pemphigus
15 lug 2026
Switching to brodalumab after failure of IL-17A inhibitors
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients
15 lug 2026
Pregnancy-associated melanoma
Pregnancy-associated melanoma: New evidence
25 giu 2026
Treatment-associated phenotype switching between psoriasis
Psoriasis and atopic dermatitis (AD) are traditionally viewed as distinct inflammatory skin diseases
25 giu 2026
Prevalence of Familial Melanoma Genes and Cancer Risk
The prevalence of germline pathogenic variants in familial melanoma genes
25 giu 2026
Intradermal tranexamic acid and melasma
Melasma is a common acquired pigmentary disorder characterized by symmetrical hyperpigmentation, mainly affecting sun-exposed areas of the face and neck.
08 giu 2026
Diagnosing and Managing Stevens-Johnson Syndrome
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening reactions associated with long-term disabling sequelae